Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.409EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.83EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.310EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.362.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.162EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Y.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.86EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.154EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.137EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.446EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.76 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.398EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.163EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.3 (Theta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.9.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.221.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.62EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.39.1.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.15 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.134EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.39.1.3 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.2 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
M.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.82 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.23.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.466.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.213EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
HW.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
KW.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-22667.5Germany
XDENCorman-NCACATTGGCACCCGCAATC1957.892870628724F-22667.5Germany
KE.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22683US
EG.14NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22683US
XBB.1.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22683US
C.28NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22683US
GS.7.1ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-22722.4Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used